Toripalimab Combined With Gemcitabine/5--fluoropyrimidine for Advanced Cholangiocarcinoma

Clinical trial NCT03982680 · UNKNOWN

Trial details

NCT number: NCT03982680
Sponsor: Jiangmen Central Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Cholangiocarcinoma

Start date: 2019-07-13
Primary completion: 2021-05-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.